---
schema_version: "secwatch.filing_event.v1"
accession: "0001193805-23-001637"
form_type: "8-K"
ticker: "IMUX"
cik: "0001280776"
company_name: "IMMUNIC, INC."
filed_at: "2023-12-21T23:59:59+00:00"
generated_at: "2026-06-07T08:49:14.698990+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Immunic extends CEO, CMO, CSO contracts through Dec 2026 with revised compensation

## Summary
- CEO Daniel Vitt: annual salary EUR 565,653, target bonus up to EUR 311,573, term through Dec 31, 2026.
- CMO Andreas Muehler: EUR 231,825 salary (AG) plus $250,000 (Inc.) salary, 50% time to each, term through 2026.
- CSO Hella Kohlhof: annual salary EUR 403,375, target bonus up to EUR 161,350, term through Dec 31, 2026.
- All three got accelerated stock option vesting on termination and a one-year post-termination exercise period.
- New contracts effective Jan 1, 2024, replacing prior agreements; Muehler also signed a separate U.S. employment agreement.

## SEC filing metadata
- accession: 0001193805-23-001637
- form_type: 8-K
- ticker: IMUX
- cik: 0001280776
- company_name: IMMUNIC, INC.
- filed_at: 2023-12-21T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/0001193805-23-001637-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1280776/000119380523001637/e619130_8k-immunic.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193805-23-001637
- JSON: https://secwatch.observer/filing/0001193805-23-001637.json
- Plain text: https://secwatch.observer/filing/0001193805-23-001637.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.